Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Where to Get The New Fat-Dissolving Injectable in NYC

shutterstock_140908618

Nobody wants a double chin. Luckily for you, Haute Living has the exclusive scoop on how to fit the issue in NYC. The first and only FDA-approved injectable drug is finally here.

Unanimously recommended for approval, KYBELLA, formerly known as ATX-101, is an injectable drug that contours and improves the appearance of submental fullness due to submental fat. Created by Kythera Biopharmaceuticals Inc., the drug was approved by the FDA in April and became available June 19th to dermatologists and plastic surgeons who completed training at the drug company’s facilities. Training began earlier this month, with an extensive training program to begin later this summer.

So how does the non-surgical treatment works? When administered into the fat below the skin, KYBELLA destroys the fat cells. Patients can receive up to 50 injections in one single treatment, with up to six treatments administered no less than one month apart.

According to Kythera Biopharmaceuticals Inc., during clinical trials patients’ experienced visible results in two to four treatments. Treatments resulted in high patient satisfaction. In fact, 79 percent of patients reported satisfaction with their appearance regarding their face and chin. When asked how happy, bothered, self-conscious, embarrassed, old and overweight they felt following treatment in relation to the amount of their submental fat, patients reported improvement in the visual and emotional impact of submental fat.

“Many people complain that a double chin makes them feel older and heavier than they actually are,” said Frederick C. Beddingfield, III, M.D., Ph.D., Chief Medical Officer, KYTHERA. “With KYBELLA, for the first time, people have access to a non-surgical solution to address this long-standing but common aesthetic complaint. KYBELLA causes the destruction of fat cells, so once the aesthetic response is achieved, retreatment is not expected.”

If you’re in the tri-state area and would like to get rid of your pesky double chin, Dr. Marina Peredo is one of the first New York City dermatologists to offer the KYBELLA treatment at her Manhattan practice, Skinfluence.

Visit Skinfluence to inquire about KYBELLA treatments.

(Photo via Shutterstock)